Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease
Abstract Chronic cholestatic liver diseases are characterized by injury of the bile ducts and hepatocytes caused by accumulated bile acids (BAs) and inflammation. Wnt/β‐catenin signaling is implicated in organ fibrosis; however, its role in cholestatic liver fibrosis remains unclear. Therefore, we e...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-10-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.2043 |